GILEAD SCIENCES, INC. - Insider Non-Derivative Transactions at Xilio Therapeutics, Inc. (XLO) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 18, 2024, GILEAD SCIENCES, INC.'s relationship to Xilio Therapeutics, Inc. (XLO) is TenPercentOwner, and currently has 9,105,451 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other XLO insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

GILEAD SCIENCES, INC. - Insider Non-Derivative Transactions of XLO Common Stock

GILEAD SCIENCES, INC. - Insider Non-Derivative Transactions at XLO

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 19, 2024	P -- (Common Stock)	1759978	1.04	9105451
Apr 3, 2024	P -- (Common Stock)	485250	0.76	7345473